14.93
price up icon6.72%   0.94
after-market Dopo l'orario di chiusura: 14.70 -0.23 -1.54%
loading
Precedente Chiudi:
$13.99
Aprire:
$13.83
Volume 24 ore:
788.32K
Relative Volume:
0.70
Capitalizzazione di mercato:
$1.06B
Reddito:
$133.62M
Utile/perdita netta:
$-177.37M
Rapporto P/E:
-5.1661
EPS:
-2.89
Flusso di cassa netto:
$23.50M
1 W Prestazione:
+7.41%
1M Prestazione:
+20.11%
6M Prestazione:
+83.42%
1 anno Prestazione:
-36.47%
Intervallo 1D:
Value
$13.73
$15.09
Intervallo di 1 settimana:
Value
$13.57
$15.29
Portata 52W:
Value
$6.92
$27.24

Xencor Inc Stock (XNCR) Company Profile

Name
Nome
Xencor Inc
Name
Telefono
626-305-5900
Name
Indirizzo
465 N. HALSTEAD ST., PASADENA, CA
Name
Dipendente
250
Name
Cinguettio
Name
Prossima data di guadagno
2025-08-01
Name
Ultimi documenti SEC
Name
XNCR's Discussions on Twitter

Confronta XNCR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
XNCR
Xencor Inc
14.93 999.03M 133.62M -177.37M 23.50M -2.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
437.15 110.25B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
693.50 73.04B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
449.16 59.98B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
907.98 54.90B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
193.22 40.73B 447.02M -1.18B -906.14M -6.1812

Xencor Inc Stock (XNCR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-29 Aggiornamento Barclays Underweight → Overweight
2025-09-17 Ripresa Barclays Underweight
2025-09-03 Downgrade BofA Securities Buy → Neutral
2025-04-21 Iniziato William Blair Outperform
2024-12-12 Iniziato Wells Fargo Overweight
2024-12-02 Aggiornamento Piper Sandler Neutral → Overweight
2024-04-16 Reiterato BTIG Research Buy
2024-02-28 Downgrade Piper Sandler Overweight → Neutral
2023-05-19 Iniziato BofA Securities Buy
2022-12-06 Iniziato Cowen Outperform
2022-10-13 Aggiornamento Raymond James Outperform → Strong Buy
2022-09-21 Iniziato JP Morgan Overweight
2022-07-06 Ripresa Canaccord Genuity Buy
2022-02-11 Iniziato BMO Capital Markets Outperform
2022-01-21 Iniziato SMBC Nikko Outperform
2021-12-15 Iniziato H.C. Wainwright Buy
2021-10-15 Ripresa BTIG Research Buy
2021-02-24 Aggiornamento Raymond James Mkt Perform → Outperform
2020-03-04 Iniziato Barclays Underweight
2020-02-25 Aggiornamento Guggenheim Neutral → Buy
2020-01-30 Iniziato RBC Capital Mkts Outperform
2019-11-20 Ripresa Guggenheim Neutral
2019-08-07 Downgrade Guggenheim Buy → Neutral
2019-08-07 Downgrade Raymond James Outperform → Mkt Perform
2019-06-13 Iniziato Mizuho Buy
2019-04-12 Iniziato Guggenheim Buy
2019-03-27 Iniziato Berenberg Buy
2019-03-15 Iniziato Raymond James Outperform
2018-09-10 Ripresa BTIG Research Buy
2018-03-28 Ripresa Leerink Partners Outperform
2017-03-02 Iniziato Instinet Neutral
2017-03-02 Reiterato Wedbush Outperform
2016-10-04 Iniziato Piper Jaffray Overweight
2015-12-22 Iniziato Canaccord Genuity Buy
2015-08-05 Reiterato MLV & Co Buy
2015-02-12 Reiterato Oppenheimer Outperform
2015-01-28 Reiterato MLV & Co Buy
2014-07-11 Iniziato Oppenheimer Outperform
Mostra tutto

Xencor Inc Borsa (XNCR) Ultime notizie

pulisher
Nov 16, 2025

Is Xencor Inc. (XE9) stock undervalued historicallyJuly 2025 Levels & Real-Time Buy Signal Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Why Xencor Inc. stock remains on buy listsDip Buying & Fast Momentum Stock Entry Tips - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Should you hold or exit Xencor Inc. nowWeekly Trade Report & Weekly Breakout Watchlists - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

What candlestick patterns are forming on Xencor Inc.Market Rally & Verified Momentum Stock Watchlist - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

What to expect from Xencor Inc. in the next 30 days2025 Investor Takeaways & Target Return Focused Picks - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Los Angeles Capital Management LLC Purchases 83,143 Shares of Xencor, Inc. $XNCR - MarketBeat

Nov 15, 2025
pulisher
Nov 15, 2025

Tick level data insight on Xencor Inc. volatilityQuarterly Trade Report & Expert Verified Stock Movement Alerts - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Can Xencor Inc. stock continue upward trendMarket Activity Report & Safe Investment Capital Preservation Plans - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Is Xencor Inc. (XE9) stock nearing a technical breakoutJuly 2025 Opening Moves & Technical Pattern Alert System - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Why analysts remain bullish on Xencor Inc. stock2025 AllTime Highs & Verified Momentum Stock Alerts - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

How Xencor Inc. stock compares to growth peersGold Moves & High Accuracy Investment Signals - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Does Xencor’s Sharply Reduced Loss in Q3 2025 Signal a Turnaround for XNCR? - simplywall.st

Nov 14, 2025
pulisher
Nov 14, 2025

How Xencor Inc. (XE9) stock benefits from digital adoptionQuarterly Trade Review & Accurate Technical Buy Alerts - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Xencor (XNCR): Assessing Valuation After Net Losses Narrow Sharply in Latest Earnings - Yahoo Finance

Nov 14, 2025
pulisher
Nov 13, 2025

Will Sharply Reduced Net Losses Signal a Turning Point for Xencor's (XNCR) Path to Profitability? - Yahoo Finance

Nov 13, 2025
pulisher
Nov 13, 2025

Can a trend reversal in Xencor Inc. lead to recoveryTrade Volume Summary & Verified Technical Trade Signals - newser.com

Nov 13, 2025
pulisher
Nov 12, 2025

Xencor (NASDAQ:XNCR) Shares Up 8.7%What's Next? - MarketBeat

Nov 12, 2025
pulisher
Nov 12, 2025

Xencor at TD Cowen Summit: Strategic Focus on Oncology and Autoimmune - Investing.com Nigeria

Nov 12, 2025
pulisher
Nov 12, 2025

Xencor Inc. stock trend forecastWeekly Trend Recap & Capital Efficient Trade Techniques - newser.com

Nov 12, 2025
pulisher
Nov 12, 2025

Will Xencor Inc. (XE9) stock return to pre crash levelsJuly 2025 Catalysts & Low Risk Growth Stock Ideas - newser.com

Nov 12, 2025
pulisher
Nov 11, 2025

Positive readouts validate pipelines, fuel drug developer rally - BioWorld MedTech

Nov 11, 2025
pulisher
Nov 11, 2025

Why institutional investors increase stakes in Xencor Inc. (XE9) stockJuly 2025 Big Picture & Low Drawdown Trading Techniques - newser.com

Nov 11, 2025
pulisher
Nov 10, 2025

Xencor to Participate at Upcoming Investor Conferences - Business Wire

Nov 10, 2025
pulisher
Nov 10, 2025

Is Xencor Inc. stock gaining market shareRate Cut & Free Weekly Watchlist of Top Performers - newser.com

Nov 10, 2025
pulisher
Nov 10, 2025

Cantor Fitzgerald Predicts Increased Earnings for Xencor - MarketBeat

Nov 10, 2025
pulisher
Nov 10, 2025

Wedbush Estimates Xencor's FY2025 Earnings (NASDAQ:XNCR) - MarketBeat

Nov 10, 2025
pulisher
Nov 10, 2025

FY2025 Earnings Estimate for Xencor Issued By William Blair - MarketBeat

Nov 10, 2025
pulisher
Nov 10, 2025

Leerink Partnrs Increases Earnings Estimates for Xencor - MarketBeat

Nov 10, 2025
pulisher
Nov 10, 2025

Published on: 2025-11-09 23:13:10 - newser.com

Nov 10, 2025
pulisher
Nov 08, 2025

Can volume confirm reversal in Xencor Inc.2025 Momentum Check & Daily Stock Momentum Reports - newser.com

Nov 08, 2025
pulisher
Nov 07, 2025

Xencor (NASDAQ:XNCR) Price Target Cut to $18.00 by Analysts at JPMorgan Chase & Co. - MarketBeat

Nov 07, 2025
pulisher
Nov 07, 2025

Wedbush Reaffirms "Outperform" Rating for Xencor (NASDAQ:XNCR) - MarketBeat

Nov 07, 2025
pulisher
Nov 07, 2025

Xencor (NASDAQ:XNCR) Given New $19.00 Price Target at Royal Bank Of Canada - MarketBeat

Nov 07, 2025
pulisher
Nov 07, 2025

Xencor (NASDAQ:XNCR) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says - MarketBeat

Nov 07, 2025
pulisher
Nov 07, 2025

Tools to assess Xencor Inc.’s risk profileWeekly Market Summary & Target Return Focused Stock Picks - newser.com

Nov 07, 2025
pulisher
Nov 07, 2025

Xencor (XNCR) Gets a Hold from Bank of America Securities - The Globe and Mail

Nov 07, 2025

Xencor Inc Azioni (XNCR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$39.16
price down icon 1.43%
$30.26
price up icon 0.07%
$104.15
price down icon 1.20%
$103.09
price down icon 0.76%
biotechnology ONC
$365.82
price down icon 0.69%
$193.22
price up icon 1.18%
Capitalizzazione:     |  Volume (24 ore):